Oromucosal Dosage Forms: Novel Formulation Strategies, Delivery and Release

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".

Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 2716

Special Issue Editors


E-Mail Website
Guest Editor
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90123 Palermo, Italy
Interests: controlled drug release; bio-adhesive buccal delivery systems; sublingual delivery; lipid-micro and nanoparticles; drug absorption from the oral cavity
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90123 Palermo, Italy
Interests: ex-vivo permeation; nanosystems; drug delivery systems; biopolymers; buccal tablets; microparticles; dissolution kinetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In the last few decades, the oral cavity has attracted the interest of the scientific community as a promising alternative route for drug administration. Indeed, the oral mucosa could be particularly interesting for the treatment of local affections as well as for systemic therapies via precisely designed formulations and careful selection of the application site. Both the buccal and sublingual mucosae are highly vascularized, presenting several advantages such as the opportunity to bypass the gastrointestinal tract and first-pass metabolism in the liver. When the sublingual mucosa is chosen as an administration site, the rapid onset of action results in the delivery route being more comfortable and convenient than the intravenous route. Moreover, mouth pathologies ranging from periodontitis to mucositis up to cancerous lesions can greatly benefit from targeted locoregional drug delivery in a manner whereby systemic side effects are avoided, which enhances the patient’s quality of life.

To obtain significant therapeutic results, the design and characterization of innovative pharmaceutical dosage forms suitable for oral cavity application are of crucial importance. This includes the choice of innovative compositions, production techniques and drug release mechanisms.

Therefore, this Special Issue welcomes original research articles and reviews that cover all the aspects of the design, manufacturing, characterization and final formulation of oromucosal drug delivery systems specifically designed to be applied on the oral cavity both for systemic and locoregional therapies.

Research areas of interest include (but are not limited to) the following technologies: film, patch, matrix tablet, nanocomposite, IPEC and microparticles.

Dr. Viviana De Caro
Dr. Giulia Di Prima
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • buccal route
  • sublingual route
  • oromucosal delivery
  • mucoadhesion
  • mucosal permeability
  • drug delivery systems
  • kinetics of drug release
  • mechanism of drug discharge
  • systemic therapy
  • locoregional buccal treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

24 pages, 2270 KiB  
Article
Spray-Dried Cytisine-Loaded Matrices: Development of Transbuccal Sustained-Release Tablets as a Promising Tool in Smoking Cessation Therapy
by Giuseppe Angellotti, Giulia Di Prima, Amalia Giulia Scarpaci, Fabio D’Agostino, Giuseppina Campisi and Viviana De Caro
Pharmaceutics 2022, 14(8), 1583; https://doi.org/10.3390/pharmaceutics14081583 - 29 Jul 2022
Cited by 2 | Viewed by 1975
Abstract
Cytisine (CYT) has emerged as a promising molecule to treat nicotine addiction, since it acts as a partial agonist of nicotinic acetylcholine receptors. However, its unfavorable pharmacokinetic properties lead to multiple administrations per day, reducing the patient’s compliance and increasing the side effects. [...] Read more.
Cytisine (CYT) has emerged as a promising molecule to treat nicotine addiction, since it acts as a partial agonist of nicotinic acetylcholine receptors. However, its unfavorable pharmacokinetic properties lead to multiple administrations per day, reducing the patient’s compliance and increasing the side effects. To overcome these drawbacks, CYT buccal administration is here proposed. Firstly, CYT stability in the buccal environment was assessed and its intrinsic ability to permeate/penetrate the tissue was determined by applying CYT solutions at increasing concentrations. Furthermore, a spray-drying method was selected and optimized as it is an eco-friendly, easily scalable and effective technique to obtain uniform and reproducible CYT-loaded (5% w/w) pharmaceutical powders, which were directly compressed, thus obtaining different buccal delivery systems (BDSs). The obtained BDSs were homogeneous and reproducible and embedded CYT in its amorphous form. The mechanism of CYT release was evaluated in vitro and found to be mainly driven by a Fickian diffusion phenomenon. Predominantly, the ex vivo permeation assays highlighted the ability of the BDSs to enhance CYT permeation, also producing high drug fluxes through the mucosa. Speculative mathematical evaluations based on the already-known CYT pharmacokinetic parameters showed that CYT-loaded BDSs could potentially be sufficient to obtain a therapeutic effect, thus making the reported formulations suitable candidates for further in vivo trials. Full article
Show Figures

Figure 1

Back to TopTop